Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: CELLeBRAIN Co., Ltd.
February 27, 2026
CELLeBRAIN Co., Ltd.
Orphan Drug Designation
Jeonju-si
1-50 employees
treatment of malignant glioma
Disease Area:
Rare Diseases
Source
Scroll to Top